chr5-45695954-C-A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_021072.4(HCN1):​c.140G>T​(p.Gly47Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00589 in 1,332,860 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G47R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0035 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0062 ( 26 hom. )

Consequence

HCN1
NM_021072.4 missense

Scores

1
4
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.91

Publications

3 publications found
Variant links:
Genes affected
HCN1 (HGNC:4845): (hyperpolarization activated cyclic nucleotide gated potassium channel 1) The membrane protein encoded by this gene is a hyperpolarization-activated cation channel that contributes to the native pacemaker currents in heart and neurons. The encoded protein can homodimerize or heterodimerize with other pore-forming subunits to form a potassium channel. This channel may act as a receptor for sour tastes. [provided by RefSeq, Oct 2011]
HCN1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 24
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • generalized epilepsy with febrile seizures plus
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • generalized epilepsy with febrile seizures plus, type 10
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005699843).
BP6
Variant 5-45695954-C-A is Benign according to our data. Variant chr5-45695954-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 193442.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 523 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HCN1NM_021072.4 linkc.140G>T p.Gly47Val missense_variant Exon 1 of 8 ENST00000303230.6 NP_066550.2 O60741Q86WJ6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HCN1ENST00000303230.6 linkc.140G>T p.Gly47Val missense_variant Exon 1 of 8 1 NM_021072.4 ENSP00000307342.4 O60741
HCN1ENST00000673735.1 linkc.140G>T p.Gly47Val missense_variant Exon 1 of 9 ENSP00000501107.1 A0A669KB45
HCN1ENST00000634658.1 linkc.140G>T p.Gly47Val missense_variant Exon 1 of 2 3 ENSP00000489134.1 A0A0U1RQR7
HCN1ENST00000638054.1 linkn.-229G>T upstream_gene_variant 5

Frequencies

GnomAD3 genomes
AF:
0.00349
AC:
523
AN:
149810
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000974
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00252
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000627
Gnomad FIN
AF:
0.00213
Gnomad MID
AF:
0.00325
Gnomad NFE
AF:
0.00612
Gnomad OTH
AF:
0.00388
GnomAD2 exomes
AF:
0.00661
AC:
143
AN:
21648
AF XY:
0.00673
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00247
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00451
Gnomad NFE exome
AF:
0.0118
Gnomad OTH exome
AF:
0.00383
GnomAD4 exome
AF:
0.00620
AC:
7333
AN:
1182940
Hom.:
26
Cov.:
32
AF XY:
0.00613
AC XY:
3540
AN XY:
577248
show subpopulations
African (AFR)
AF:
0.00108
AC:
25
AN:
23052
American (AMR)
AF:
0.00206
AC:
21
AN:
10186
Ashkenazi Jewish (ASJ)
AF:
0.0000612
AC:
1
AN:
16350
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25844
South Asian (SAS)
AF:
0.000768
AC:
35
AN:
45562
European-Finnish (FIN)
AF:
0.00287
AC:
80
AN:
27854
Middle Eastern (MID)
AF:
0.000898
AC:
3
AN:
3340
European-Non Finnish (NFE)
AF:
0.00707
AC:
6945
AN:
983012
Other (OTH)
AF:
0.00467
AC:
223
AN:
47740
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
421
842
1262
1683
2104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
292
584
876
1168
1460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00349
AC:
523
AN:
149920
Hom.:
2
Cov.:
32
AF XY:
0.00335
AC XY:
245
AN XY:
73212
show subpopulations
African (AFR)
AF:
0.000971
AC:
40
AN:
41196
American (AMR)
AF:
0.00252
AC:
38
AN:
15078
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3450
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4960
South Asian (SAS)
AF:
0.000627
AC:
3
AN:
4782
European-Finnish (FIN)
AF:
0.00213
AC:
21
AN:
9840
Middle Eastern (MID)
AF:
0.00350
AC:
1
AN:
286
European-Non Finnish (NFE)
AF:
0.00612
AC:
412
AN:
67346
Other (OTH)
AF:
0.00384
AC:
8
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
27
55
82
110
137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00346
Hom.:
0
Bravo
AF:
0.00340
ExAC
AF:
0.00177
AC:
27

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

HCN1: PP3, BS2 -

May 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 24747641) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
Nov 16, 2017
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 23, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Apr 19, 2018
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Developmental and epileptic encephalopathy, 24;C5193120:Generalized epilepsy with febrile seizures plus, type 10 Benign:1
-
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

HCN1 NM_021072.3 exon 1 p.Gly47Val (c.140G>T):This variant has been reported in the literature in 1 individual with early infantile epileptic encephalopathy (Nava 2014 PMID:24747641). However this variant is present in 0.6% (412/67356) of European alleles including 2 homozygotes in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/5-45695954-C-A?dataset=gnomad_r3). This variant is present in ClinVar, with several labs classifying this variant as Likely Benign or Benign(Variation ID:193442). Evolutionary conservation for this variant is limited or unavailable; computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant suggests that this variant does not cause disease, but requires further evidence. Therefore this variant is classified as likely benign. -

Developmental and epileptic encephalopathy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

HCN1-related disorder Benign:1
Feb 23, 2022
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Uncertain
-0.060
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.10
T;T
Eigen
Benign
-0.63
Eigen_PC
Benign
-0.60
FATHMM_MKL
Benign
0.18
N
LIST_S2
Benign
0.55
T;T
MetaRNN
Benign
0.0057
T;T
MetaSVM
Uncertain
0.40
D
MutationAssessor
Benign
0.0
N;.
PhyloP100
1.9
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-0.84
N;.
REVEL
Uncertain
0.38
Sift
Benign
0.20
T;.
Sift4G
Benign
0.27
T;T
Polyphen
0.36
B;.
Vest4
0.17
MVP
0.72
MPC
3.0
ClinPred
0.043
T
GERP RS
3.3
PromoterAI
-0.011
Neutral
Varity_R
0.075
gMVP
0.31
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs544994462; hg19: chr5-45696056; COSMIC: COSV57523921; COSMIC: COSV57523921; API